Abstract
In candidate gene era, dozens of single-nucleotide polymorphisms (SNPs) within renin–angiotensin–aldosterone system (RAAS) have been reported to be significantly associated with hypertension. However, the unbiased genome-wide association studies (GWAS) rarely identified the SNPs within RAAS were associated with hypertension or blood pressure (BP) traits. In order to figure out whether genetic polymorphisms of RAAS are really associated with hypertension, we systemically searched the GWAS Catalogue and identified all the known RAAS genes and relevant diseases/traits. After data processing, we found that polymorphisms within REN, AGT, ACE2, CYP11B2, ATP6AP2 and HSD11B2 were not associated with any disease or trait. SNPs within ACE, AGTR1, AGTR2, MAS1, RENBP and NR3C2 were associated with other diseases or traits, but showed no direct connection with hypertension. The only SNP associated with a BP trait, systolic BP was rs17367504. However, it is located in the intronic region of MTHFR near many plausible candidate genes, including CLCN6, NPPA, NPPB and AGTRAP. Therefore, the effect of RAAS polymorphisms may have been overestimated during the ‘candidate gene era’. In the time of ‘precision medicine’, the power of RAAS variants needs to be reconsidered when evaluating one’s susceptibility of hypertension.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
DeMello WC, Re RN . Systemic versus local renin angiotensin systems. An overview. In: DeMello WC, Re RN (eds). Renin Angiotensin System and Cardiovascular Disease. Springer: New York, NY, USA, 2010, pp 1–5.
Urata H, Healy B, Stewart RW, Bumpus FM, Husain A . Angiotensin II-forming pathways in normal and failing human hearts. Circ Res 1990; 66 (4): 883–890.
Quinn SJ, Williams GH . Regulation of aldosterone secretion. Annu Rev Physiol 1988; 50: 409–426.
Te Riet L, van Esch JH, Roks AJ, van den Meiracker AH, Danser AH . Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res 2015; 116 (6): 960–975.
Singh KhD, Karthikeyan M . Combined sequence and sequence-structure-based methods for analyzing RAAS gene SNPs: a computational approach. J Recept Signal Transduct Res 2014; 34 (6): 513–526.
Zhao Q, Kelly TN, Li C, He J . Progress and future aspects in genetics of human hypertension. Curr Hypertens Rep 2013; 15 (6): 676–686.
Spencer CC, Su Z, Donnelly P, Marchini J . Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip. PLoS Genet 2009; 5 (5): e1000477.
The Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447 (7145): 661–678.
The International Consortium for Blood Pressure Genome-Wide Association Studies The International Consortium for Blood Pressure Genome-Wide Association Studies, Ehret GB The International Consortium for Blood Pressure Genome-Wide Association Studies, Munroe PB The International Consortium for Blood Pressure Genome-Wide Association Studies, Rice KM The International Consortium for Blood Pressure Genome-Wide Association Studies, Bochud M The International Consortium for Blood Pressure Genome-Wide Association Studies, Johnson AD et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011; 478 (7367): 103–109.
Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, Sim X et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet 2011; 43 (6): 531–538.
Surendran P, Drenos F, Young R, Warren H, Cook JP, Manning AK et al. Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Nat Genet 2016; 48 (10): 1151–1161.
Ehret GB, Ferreira T, Chasman DI, Jackson AU, Schmidt EM, Johnson T et al. The genetics of blood pressure regulation and its target organs from association studies in 342 415 individuals. Nat Genet 2016; 48 (10): 1171–1184.
Liu C, Kraja AT, Smith JA, Brody JA, Franceschini N, Bis JC et al. Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci. Nat Genet 2016; 48 (10): 1162–1170.
Padmanabhan S, Caulfield M, Dominiczak AF . Genetic and molecular aspects of hypertension. Circ Res 2015; 116 (6): 937–959.
Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 2014; 42 (Database issue): D1001–D1006.
Warrington NM, Zhu G, Dy V, Heath AC, Madden PA, Hemani G et al. Genome-wide association study of blood lead shows multiple associations near ALAD. Hum Mol Genet 2015; 24 (13): 3871–3879.
Wright FA, Strug LJ, Doshi VK, Commander CW, Blackman SM, Sun L et al. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet 2011; 43 (6): 539–546.
Corvol H, Blackman SM, Boelle PY, Gallins PJ, Pace RG, Stonebraker JR et al. Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis. Nat Commun 2015; 6: 8382.
Li J, Lange LA, Sabourin J, Duan Q, Valdar W, Willis MS et al. Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study. J Hum Genet 2015; 60 (12): 755–761.
Wong EH, So HC, Li M, Wang Q, Butler AW, Paul B et al. Common variants on Xq28 conferring risk of schizophrenia in Han Chinese. Schizophr Bull 2014; 40 (4): 777–786.
Rawal R, Teumer A, Volzke H, Wallaschofski H, Ittermann T, Asvold BO et al. Meta-analysis of two genome-wide association studies identifies four genetic loci associated with thyroid function. Hum Mol Genet 2012; 21 (14): 3275–3282.
Yu B, Zheng Y, Alexander D, Morrison AC, Coresh J, Boerwinkle E . Genetic determinants influencing human serum metabolome among African Americans. PLoS Genet 2014; 10 (3): e1004212.
Shin SY, Fauman EB, Petersen AK, Krumsiek J, Santos R, Huang J et al. An atlas of genetic influences on human blood metabolites. Nat Genet 2014; 46 (6): 543–550.
Mosley JD, Shaffer CM, Van Driest SL, Weeke PE, Wells QS, Karnes JH et al. A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough. Pharmacogenomics J 2016; 16 (3): 231–237.
Bis JC, Sitlani C, Irvin R, Avery CL, Smith AV, Sun F et al. Drug-Gene interactions of antihypertensive medications and risk of incident cardiovascular disease: a pharmacogenomics study from the CHARGE Consortium. PLoS ONE 2015; 10 (10): e0140496.
Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009; 41 (6): 666–676.
Johnson AD, Newton-Cheh C, Chasman DI, Ehret GB, Johnson T, Rose L et al. Association of hypertension drug target genes with blood pressure and hypertension in 86 588 individuals. Hypertension 2011; 57 (5): 903–910.
Cowley AW Jr, Nadeau JH, Baccarelli A, Berecek K, Fornage M, Gibbons GH et al. Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension 2012; 59 (5): 899–905.
Millis RM . Epigenetics and hypertension. Curr Hypertens Rep 2011; 13 (1): 21–28.
Bogdarina I, Welham S, King PJ, Burns SP, Clark AJ . Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ Res 2007; 100 (4): 520–526.
Zhang D, Yu ZY, Cruz P, Kong Q, Li S, Kone BC . Epigenetics and the control of epithelial sodium channel expression in collecting duct. Kidney Int 2009; 75 (3): 260–267.
Kohlstedt K, Shoghi F, Muller-Esterl W, Busse R, Fleming I . CK2 phosphorylates the angiotensin-converting enzyme and regulates its retention in the endothelial cell plasma membrane. Circ Res 2002; 91 (8): 749–756.
Oppermann M, Freedman NJ, Alexander RW, Lefkowitz RJ . Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C. J Biol Chem 1996; 271 (22): 13266–13272.
Su Z, Zimpelmann J, Burns KD . Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 2006; 69 (12): 2212–2218.
Paradis P, Schiffrin EL . Renin-angiotensin-aldosterone system and pathobiology of hypertension. In: DeMello WC, Re RN (eds). Renin Angiotensin System and Cardiovascular Disease. Springer: New York, NY, USA, 2010, pp 35–57.
Acknowledgements
This study was supported by the grants from National Natural Science Foundation of China (81402747), Zhejiang Natural Science Foundation (LQ13C060001), Ningbo Natural Science Foundation (2016A610085), as well as the KC Wong Magna Fund in Ningbo University.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Ji, LD., Li, JY., Yao, BB. et al. Are genetic polymorphisms in the renin–angiotensin–aldosterone system associated with essential hypertension? Evidence from genome-wide association studies. J Hum Hypertens 31, 695–698 (2017). https://doi.org/10.1038/jhh.2017.29
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2017.29
This article is cited by
-
Psoriasis and cardiovascular disease risk in European and East Asian populations: evidence from meta-analysis and Mendelian randomization analysis
BMC Medicine (2022)
-
Evolutionary trilogy of malaria, angiotensin II and hypertension: deeper insights and the way forward
Journal of Human Hypertension (2022)
-
Development and application of low-cost T-ARMS-PCR assay for AGT and CYP11B1 gene polymorphisms
Molecular Biology Reports (2019)
-
Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
Lipids in Health and Disease (2018)
-
DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics
Heart Failure Reviews (2018)